Boule Diagnostics AB (BDABF) Ratios
Boule Diagnostics AB Ratios
BDABF's free cash flow for Q3 2026 was $4.20M. For the 2026 fiscal year, BDABF's free cash flow was decreased by $-2.30M and operating cash flow was $6.50M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.09 | 0.97 | 1.38 | 1.68 | 1.15 |
| Quick Ratio | 0.80 | 0.75 | 1.07 | 1.31 | 0.87 |
| Cash Ratio | 0.09 | 0.09 | 0.18 | 0.48 | 0.18 |
| Solvency Ratio | 0.05 | -0.62 | 0.18 | 0.13 | 0.16 |
| Operating Cash Flow Ratio | 0.00 | 0.18 | 0.25 | -0.06 | 0.20 |
| Short-Term Operating Cash Flow Coverage | 0.01 | 0.36 | 0.61 | -0.12 | 0.47 |
| Net Current Asset Value | $ -76.60M | $ -65.80M | $ -78.00K | $ 40.95M | $ -33.92M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.48 | 0.33 | 0.22 | 0.25 | 0.27 |
| Debt-to-Equity Ratio | 1.34 | 0.72 | 0.35 | 0.41 | 0.53 |
| Debt-to-Capital Ratio | 0.57 | 0.42 | 0.26 | 0.29 | 0.34 |
| Long-Term Debt-to-Capital Ratio | 0.26 | 0.16 | 0.11 | 0.12 | 0.11 |
| Financial Leverage Ratio | 2.80 | 2.19 | 1.59 | 1.64 | 1.93 |
| Debt Service Coverage Ratio | 0.09 | -1.48 | 0.64 | 0.49 | 0.51 |
| Interest Coverage Ratio | 0.28 | -20.43 | 3.48 | 2.95 | 6.61 |
| Debt to Market Cap | 1.01 | 0.52 | 0.32 | 0.36 | 0.10 |
| Interest Debt Per Share | 6.32 | 5.35 | 4.55 | 7.15 | 5.87 |
| Net Debt to EBITDA | 8.83 | -0.67 | 1.95 | 1.61 | 2.11 |
| Profitability Margins | |||||
| Gross Profit Margin | 43.66% | 45.18% | 43.71% | 41.58% | 42.87% |
| EBIT Margin | 0.92% | -45.81% | 7.24% | 5.60% | 7.38% |
| EBITDA Margin | 4.72% | -45.81% | 11.55% | 10.55% | 12.02% |
| Operating Profit Margin | 0.92% | -46.08% | 6.88% | 5.29% | 7.77% |
| Pretax Profit Margin | 1.20% | -48.07% | 5.27% | 3.80% | 6.21% |
| Net Profit Margin | -0.78% | -39.97% | 4.37% | 2.32% | 5.02% |
| Continuous Operations Profit Margin | -0.78% | -39.97% | 4.37% | 2.32% | 5.02% |
| Net Income Per EBT | -64.41% | 83.17% | 82.98% | 61.05% | 80.90% |
| EBT Per EBIT | 130.53% | 104.31% | 76.59% | 71.97% | 79.87% |
| Return on Assets (ROA) | -0.81% | -37.83% | 3.31% | 1.67% | 4.07% |
| Return on Equity (ROE) | -2.27% | -82.83% | 5.26% | 2.75% | 7.87% |
| Return on Capital Employed (ROCE) | 1.72% | -78.55% | 7.12% | 5.18% | 9.98% |
| Return on Invested Capital (ROIC) | -0.73% | -45.53% | 5.02% | 2.66% | 6.26% |
| Return on Tangible Assets | -0.99% | -56.02% | 6.64% | 2.85% | 7.04% |
| Earnings Yield | -2.04% | -64.03% | 5.70% | 3.02% | 1.74% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.34 | 3.34 | 3.68 | 3.48 | 3.50 |
| Payables Turnover | 10.61 | 9.66 | 9.01 | 9.61 | 6.43 |
| Inventory Turnover | 4.68 | 5.18 | 5.15 | 4.25 | 4.48 |
| Fixed Asset Turnover | 8.44 | 14.14 | 12.90 | 9.44 | 9.77 |
| Asset Turnover | 1.04 | 0.95 | 0.76 | 0.72 | 0.81 |
| Working Capital Turnover Ratio | 92.40 | 16.14 | 5.33 | 6.50 | 12.35 |
| Cash Conversion Cycle | 152.94 | 142.04 | 129.42 | 152.80 | 128.98 |
| Days of Sales Outstanding | 109.42 | 109.38 | 99.12 | 104.99 | 104.33 |
| Days of Inventory Outstanding | 77.92 | 70.45 | 70.83 | 85.80 | 81.41 |
| Days of Payables Outstanding | 34.40 | 37.79 | 40.53 | 37.99 | 56.76 |
| Operating Cycle | 187.34 | 179.83 | 169.95 | 190.79 | 185.74 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.02 | 1.20 | 1.32 | -0.41 | 1.58 |
| Free Cash Flow Per Share | -0.11 | -1.01 | -0.80 | -3.09 | -0.48 |
| Dividend Paid and CapEx Coverage Ratio | 0.17 | 0.54 | 0.62 | -0.13 | 0.65 |
| Capital Expenditure Coverage Ratio | 0.17 | 0.54 | 0.62 | -0.15 | 0.77 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.24 | 0.31 | -0.06 | 0.28 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.08 | 0.09 | -0.02 | 0.09 |
| Free Cash Flow Yield | -2.22% | -11.27% | -7.15% | -20.46% | -0.98% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -49.10 | -1.56 | 17.53 | 33.15 | 57.50 |
| Price-to-Sales (P/S) Ratio | 0.38 | 0.62 | 0.77 | 0.77 | 2.89 |
| Price-to-Book (P/B) Ratio | 1.11 | 1.29 | 0.92 | 0.91 | 4.52 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -45.13 | -8.87 | -13.99 | -4.89 | -102.26 |
| Price-to-Operating Cash Flow Ratio | 225.07 | 7.48 | 8.52 | -37.17 | 30.92 |
| Price-to-Earnings Growth (PEG) Ratio | 0.50 | 0.00 | 0.45 | -0.72 | -0.39 |
| Enterprise Value Multiple | 16.90 | -2.04 | 8.59 | 8.90 | 26.13 |
| Enterprise Value | 390.74M | 521.04M | 566.77M | 515.02M | 1.46B |
| EV to EBITDA | 16.90 | -2.04 | 8.59 | 8.90 | 26.13 |
| EV to Sales | 0.80 | 0.93 | 0.99 | 0.94 | 3.14 |
| EV to Free Cash Flow | -94.52 | -13.26 | -18.11 | -5.97 | -111.22 |
| EV to Operating Cash Flow | 471.33 | 11.18 | 11.03 | -45.36 | 33.62 |
| Tangible Book Value Per Share | 2.18 | 2.01 | 2.46 | 5.34 | 1.98 |
| Shareholders’ Equity Per Share | 4.41 | 6.94 | 12.17 | 16.55 | 10.79 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 1.64 | 0.17 | 0.17 | 0.39 | 0.19 |
| Revenue Per Share | 12.89 | 14.38 | 14.64 | 19.61 | 16.90 |
| Net Income Per Share | -0.10 | -5.75 | 0.64 | 0.46 | 0.85 |
| Tax Burden | -0.64 | 0.83 | 0.83 | 0.61 | 0.81 |
| Interest Burden | 1.31 | 1.05 | 0.73 | 0.68 | 0.84 |
| Research & Development to Revenue | 0.12 | 0.55 | 0.09 | 0.09 | 0.09 |
| SG&A to Revenue | 0.26 | 0.29 | 0.06 | 0.06 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.22 | -0.16 | 1.31 | -0.39 | 1.20 |
Currency in SEK
